Plain-English translation of NCT07589569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a clinical trial testing a medication called for people with advanced pancreatic cancer that has a specific genetic change (KRAS G12C mutation). The study wants to see if this new targeted drug can slow down or shrink the cancer in patients whose cancer has continued to grow despite previous treatment.
Pancreatic cancer is very difficult to treat, and many patients develop resistance to standard therapies. This medication is designed to target a specific genetic mutation found in some pancreatic cancers, offering hope for patients who have run out of other options.
You likely qualify if…
You likely don't qualify if…
You will take the medication by mouth (swallowed as a pill) at a dose determined by the research team. You will attend regular clinic visits for blood tests, imaging scans, and check-ups to monitor how well the medication is working and check for any side effects. The study involves about 92 patients total across multiple hospitals, and your doctors will closely track your progress throughout your participation.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
China